Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $275.62 million. The enterprise value is $264.43 million.

Market Cap	275.62M
Enterprise Value	264.43M

Important Dates

The next confirmed earnings date is Friday, November 8, 2024, before market open.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Ocugen has 287.86 million shares outstanding. The number of shares has increased by 14.13% in one year.

Shares Outstanding	287.86M
Shares Change (YoY)	+14.13%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	1.37%
Owned by Institutions (%)	24.07%
Float	283.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.59
Forward PS	n/a
PB Ratio	14.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	36.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.41.

Current Ratio	1.04
Quick Ratio	0.87
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -114.42% and return on invested capital (ROIC) is -64.11%.

Return on Equity (ROE)	-114.42%
Return on Assets (ROA)	-49.82%
Return on Capital (ROIC)	-64.11%
Revenue Per Employee	$111,738
Profits Per Employee	-$690,815
Employee Count	65
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +145.30% in the last 52 weeks. The beta is 3.76, so Ocugen's price volatility has been higher than the market average.

Beta (5Y)	3.76
52-Week Price Change	+145.30%
50-Day Moving Average	1.06
200-Day Moving Average	1.27
Relative Strength Index (RSI)	45.51
Average Volume (20 Days)	2,911,594

Short Selling Information

The latest short interest is 51.92 million, so 18.04% of the outstanding shares have been sold short.

Short Interest	51.92M
Short Previous Month	50.62M
Short % of Shares Out	18.04%
Short % of Float	18.29%
Short Ratio (days to cover)	14.10

Income Statement

In the last 12 months, Ocugen had revenue of $7.26 million and -$44.90 million in losses. Loss per share was -$0.18.

Revenue	7.26M
Gross Profit	-23.29M
Operating Income	-51.62M
Pretax Income	-50.86M
Net Income	-44.90M
EBITDA	-50.51M
EBIT	-51.62M
Loss Per Share	-$0.18

Full Income Statement

Balance Sheet

The company has $15.70 million in cash and $6.87 million in debt, giving a net cash position of $8.83 million or $0.03 per share.

Cash & Cash Equivalents	15.70M
Total Debt	6.87M
Net Cash	8.83M
Net Cash Per Share	$0.03
Equity (Book Value)	16.93M
Book Value Per Share	0.07
Working Capital	645,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.51 million and capital expenditures -$8.95 million, giving a free cash flow of -$54.47 million.

Operating Cash Flow	-45.51M
Capital Expenditures	-8.95M
Free Cash Flow	-54.47M
FCF Per Share	-$0.19

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-710.74%
Pretax Margin	-686.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-664.95%

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.13%
Shareholder Yield	-14.13%
Earnings Yield	-16.43%
FCF Yield	-19.93%

Analyst Forecast

The average price target for Ocugen is $5.33, which is 456.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.33
Price Target Difference	456.66%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	87.51%
EPS Growth Forecast (5Y)	-39.89%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -9.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.46
Piotroski F-Score	2